Key pathway leading to neurodegeneration in early stages of ALS identified
Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for ...
Medical Xpress on MSN7d
Study identifies 51 amyotrophic lateral sclerosis-associated mutations that could help diagnose the disease
Using sequencing techniques, researchers associated 51 mutations in mitochondrial DNA with amyotrophic lateral sclerosis (ALS ...
Taiwan News3d
Amyotrophic Lateral Sclerosis (ALS) Market Outlook, Size, Trends, and Growth Opportunities by Type, Treatment, End User, and Region, 2024-2032
Report Ocean, a leading strategic consulting, and Market research firm, in its recent study, estimated Global Amayotrophic Lateral Sclerosis (ALS) Market size by value at USD 902 million in 2023.
ALS News Today5h
I AM ALS unveils new campaign aimed at supporting caregivers
This November, the nonprofit I AM ALS is launching a peer support program as part of its new campaign focused on supporting ...
Ancient Viral DNA in the Human Genome Linked to Neurodegenerative Diseases
Scientists have identified a relationship between ancient viral DNA and susceptibility to neurodegenerative diseases like ...
BioPharma Dive18h
Athira exploring strategic alternatives after Alzheimer’s failure
Founded in 2011 under the name M3 Biotechnology, Athira has been trying to develop small molecule drugs that help regenerate ...
Benzinga on MSN1d
NeuroSense Moves Toward Early Commercialization Of ALS Treatment In Canada, Eyeing $100M+ Market
NeuroSense Therapeutics Ltd., a late-clinical stage biotechnology company developing novel treatments for severe ...
ALS News Today1d
Ontario commits CA$13 million to address ALS community needs
The funding will help support the Ontario Provincial ALS Program to meet the needs of the roughly 1,300 people in Ontario ...